New Chemotherapeutic Approaches for the Treatment of Parasitic Protozoan Diseases
Martin, Michael Bernard
This item is only available for download by members of the University of Illinois community. Students, faculty, and staff at the U of I may log in with your NetID and password to view the item. If you are trying to access an Illinois-restricted dissertation or thesis, you can request a copy through your library's Inter-Library Loan office or purchase a copy directly from ProQuest.
Permalink
https://hdl.handle.net/2142/84047
Description
Title
New Chemotherapeutic Approaches for the Treatment of Parasitic Protozoan Diseases
Author(s)
Martin, Michael Bernard
Issue Date
2001
Doctoral Committee Chair(s)
Oldfield, Eric
Department of Study
Biomolecular Chemistry
Discipline
Biomolecular Chemistry
Degree Granting Institution
University of Illinois at Urbana-Champaign
Degree Name
Ph.D.
Degree Level
Dissertation
Keyword(s)
Biology, Microbiology
Language
eng
Abstract
The overall objective of this research is to develop new chemotherapeutic approaches for the treatment of parasitic protozoan diseases. The work presented in this thesis focuses on the design, synthesis, and screening (in vitro and in vivo) of bisphosphonates as a novel class of anti-parasitic agents. The infectious agents targeted in this study are Trypanosoma brucei, Trypanosoma cruzi, Toxoplasma gondii, Leishmania spp., and Plasmodium falciparum. These parasites are responsible for African sleeping sickness, South American trypanosomiasis (Chagas' disease), toxoplasmosis, leishmaniasis, and malaria, respectively. The studies contained within this thesis were carried out in three main areas: (a) demonstration of selective anti-parasitic activity of bisphosphonates, (b) elucidation of molecular mechanism and identification of the molecular parasitic target of bisphosphonates, and (c) enhancement of bisphosphonate activity through rational drug design. All of the findings reported in this volume suggest that bisphosphonates appear to be a promising class of compounds for the development of new drugs effective in the treatment of parasitic diseases.
Use this login method if you
don't
have an
@illinois.edu
email address.
(Oops, I do have one)
IDEALS migrated to a new platform on June 23, 2022. If you created
your account prior to this date, you will have to reset your password
using the forgot-password link below.
